# Vitroscope AS funding rounds and investors

As of 4 Nov 2026, Vitroscope AS has raised $5M across 1 verified round on record; latest: $5M seed round led by Cerberus Ventures and YZR Capital, announced 3 Nov 2026.

A Trondheim, Norway-based biotech company providing a platform for studying immune activity, treatment responses and disease mechanisms in real time

Website: https://vitroscope.com  
Headquarters: Trondheim, Norway  
Page: https://fireround.dev/companies/vitroscope

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-03 | Seed | $5M | Cerberus Ventures, YZR Capital | Arcas VC, Carles Reina, Devico Invest, Fatima Godall, Golden Egg Check, Oskari Pétas | [vitroscope.com](https://www.vitroscope.com/news/seed-raise-announcement), [businesswire.com](https://www.businesswire.com/news/home/20261103424373/en/Vitroscope-Raises-%247M-to-Scale-Live-Tissue-Platform), [tech.eu](https://tech.eu/2026/11/03/vitroscope-raises-7m-to-turn-living-human-tissue-into-a-new-source-of-drug-discovery-data) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.